Cutler Group LP Adaptimmune Therapeutics PLC Put Options Transaction History

Cutler Group LP

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2021 Oct 26, 2021	SELL	$3.44 - $6.37 $93,224 - $172,627	-27,100 Reduced 96.44%	1,000 $0
Q2 2020 Jul 22, 2020	BUY	$2.58 - $12.1 $70,176 - $329,120	27,200 Added 3022.22%	28,100 $36,000
Q1 2020 May 07, 2020	SELL	$1.2 - $4.52 $240 - $903	-200 Reduced 18.18%	900 $0
Q1 2018 May 11, 2018	BUY	$7.1 - $11.56 $7,810 - $12,716	1,100 New	1,100 $3,000

150M

60.8K

5.8K

Ticker ADAP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 163,370,000
Market Cap $96.4M
Description
Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.